IBLHL
Strong Sell
IBL HealthCare Share Price Today, Live PSX Chart & Forecast (PSX: IBLHL) IBL HealthCare Limited
Open
Rs 46.46
High
Rs 46.90
Low
Rs 45.01
Prev close
Rs 46.05
Volume
75,178
Turnover
Rs 3.4M
AI verdict · rule-engine-v2
Strong Sell
60% confidence · Short Term
Our model is bearish on IBLHL. It has called this stock correctly 54.4% of the time over 147 out-of-sample checks. See what drove this ↓
Target
Rs 43.50
Exp. return
-4.4%
IBLHL share price and analysis
IBL HealthCare Limited (IBLHL) last traded at Rs 45.52 on the Pakistan Stock Exchange, where it fell 1.15% on the session of 7 September 2026. Turnover was thin at 75,178 shares, a turnover of Rs 3.4 million, so the closing price rests on a small number of trades. Over the past year the share has traded between Rs 37.33 and Rs 80.28, putting the current price in the lower part of that range.
The price sits below both its 20-day (47.73) and 50-day (50.18) moving averages, which is the configuration usually read as a downtrend. The 14-day RSI is 34.0, a neutral reading. ADX at 20.6 indicates a weak or rangebound trend.
The company is capitalised at roughly Rs 4.5 billion and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 16.8, meaning the market is paying about Rs 16.8 for every rupee of annual earnings. Earnings per share stand at Rs 2.43. The trailing dividend yield is 2.00%, which is the income a holder receives at the current price before any capital movement. Return on equity is 6.2%. A beta of 1.25 means the share has historically moved more sharply than the wider market.
IBLHL ranks 15th of 30 Pharmaceuticals companies by market value. Its price-to-earnings ratio of 16.8 compares with the Pharmaceuticals median of 15.5, a modest premium to its sector. Its trailing dividend yield of 2.00% sits below the 3.36% median for the sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads IBLHL as strong sell over a short term horizon, at 60% confidence. Its target price is Rs 43.50, an expected return of -4.4%. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
IBLHL technical indicators — RSI, MACD & moving averages
Price chart
RSI (14)
MACD (12, 26, 9)
RSI 14
34.0
Stoch %K
13.7
ADX 14
20.6
Williams %R
-86.3
SMA 20
47.73
SMA 50
50.18
MACD
-1.169
ATR 14
0.674
BB Upper
50.56
BB Lower
44.90
Momentum
-2.14
Tech score
19
IBLHL AI forecast & accuracy
rule-engine-v2directional accuracy over 147 backtested 10-day forecasts on this stock's history
- Target
- Rs 43.50
- Stop
- Rs 46.53
- Support
- Rs 45.01
- Resistance
- Rs 50.13
- Exp. return
- -4.44%
- Risk
- 55.60/100
Why
IBLHL shows strongly bearish conditions. Overall score 33/100. Drivers: Price below the 50-day average (downtrend); Histogram negative — momentum fading; Oversold (%K 14); Neutral (34). Suggested action: Strong Sell; trend and momentum favour caution. This is an automated model assessment, not financial advice.
Generated by rule-engine-v2 from the indicators above. It does not read news, filings or management changes — see how this works.
IBLHL fundamentals & valuation ratios
- Market cap
- Rs 4.5B
- P/E
- 16.8
- EPS
- 2.43
- P/B
- 3.7
- Div yield
- 2.00%
- ROE
- 6.2%
- Beta
- 1.25
- Volatility
- 47.3%
IBLHL price history — last 30 sessions
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Mon, 7 Sep 2026 | 46.46 | 46.90 | 45.01 | 45.52 | -1.15% | 75,178 |
| Fri, 4 Sep 2026 | 45.31 | 46.05 | 45.31 | 46.05 | +1.63% | 74,900 |
| Thu, 3 Sep 2026 | 45.57 | 45.57 | 45.31 | 45.31 | -0.57% | 110,491 |
| Wed, 2 Sep 2026 | 46.45 | 46.45 | 45.57 | 45.57 | -1.89% | 49,856 |
| Tue, 1 Sep 2026 | 46.52 | 46.52 | 46.45 | 46.45 | -0.15% | 61,690 |
| Mon, 31 Aug 2026 | 46.85 | 46.85 | 46.52 | 46.52 | -0.70% | 32,333 |
| Fri, 28 Aug 2026 | 47.82 | 47.82 | 46.85 | 46.85 | -2.03% | 156,585 |
| Thu, 27 Aug 2026 | 48.30 | 48.30 | 47.82 | 47.82 | -0.99% | 99,411 |
| Tue, 25 Aug 2026 | 47.93 | 48.30 | 47.93 | 48.30 | +0.77% | 131,126 |
| Mon, 24 Aug 2026 | 47.66 | 47.93 | 47.66 | 47.93 | +0.57% | 28,291 |
| Fri, 21 Aug 2026 | 47.58 | 47.66 | 47.58 | 47.66 | +0.17% | 18,630 |
| Thu, 20 Aug 2026 | 48.74 | 48.74 | 47.58 | 47.58 | -2.38% | 130,654 |
| Wed, 19 Aug 2026 | 48.43 | 48.74 | 48.43 | 48.74 | +0.64% | 166,346 |
| Tue, 18 Aug 2026 | 48.51 | 48.51 | 48.43 | 48.43 | -0.16% | 116,758 |
| Mon, 17 Aug 2026 | 49.20 | 49.20 | 48.51 | 48.51 | -1.40% | 168,651 |
| Thu, 13 Aug 2026 | 49.44 | 49.44 | 49.20 | 49.20 | -0.49% | 75,657 |
| Wed, 12 Aug 2026 | 49.10 | 49.44 | 49.10 | 49.44 | +0.69% | 28,640 |
| Tue, 11 Aug 2026 | 49.78 | 49.78 | 49.10 | 49.10 | -1.37% | 58,966 |
| Mon, 10 Aug 2026 | 49.82 | 49.82 | 49.78 | 49.78 | -0.08% | 67,952 |
| Fri, 7 Aug 2026 | 50.13 | 50.13 | 49.82 | 49.82 | -0.62% | 41,987 |
| Thu, 6 Aug 2026 | 49.24 | 50.13 | 49.24 | 50.13 | +1.81% | 63,184 |
| Wed, 5 Aug 2026 | 49.02 | 49.24 | 49.02 | 49.24 | +0.45% | 53,836 |
| Tue, 4 Aug 2026 | 49.19 | 49.19 | 49.02 | 49.02 | -0.35% | 52,547 |
| Mon, 3 Aug 2026 | 48.96 | 49.19 | 48.96 | 49.19 | +0.47% | 121,359 |
| Fri, 31 Jul 2026 | 48.76 | 48.96 | 48.76 | 48.96 | +0.41% | 72,723 |
| Thu, 30 Jul 2026 | 49.03 | 49.03 | 48.76 | 48.76 | -0.55% | 66,630 |
| Wed, 29 Jul 2026 | 49.77 | 49.77 | 49.03 | 49.03 | -1.49% | 99,196 |
| Tue, 28 Jul 2026 | 50.19 | 50.19 | 49.77 | 49.77 | -0.84% | 81,635 |
| Mon, 27 Jul 2026 | 46.80 | 50.19 | 46.80 | 50.19 | +7.24% | 286,248 |
| Fri, 24 Jul 2026 | 47.54 | 47.54 | 46.80 | 46.80 | -1.56% | 184,131 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
Other Pharmaceuticals stocks
IBLHL is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.
All Pharmaceuticals shares on the PSX →Learn how to read this page
-
How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
-
Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
-
How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
IBLHL — frequently asked questions
What is IBLHL's share price today?
+
IBL HealthCare Limited (IBLHL) last traded at Rs 45.52 on the Pakistan Stock Exchange, down 1.15% on the session of 7 September 2026. The day's range was Rs 45.01 to Rs 46.90 on 75,178 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for IBLHL on the PSX?
+
IBLHL has traded between Rs 37.33 and Rs 80.28 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
What is IBLHL's current dividend yield?
+
IBLHL has a trailing dividend yield of 2.00%, meaning that for every Rs 100 invested at the current price a holder received about Rs 2.00 in dividends over the last twelve months. Yield moves with the share price as well as with the payout, so a rising yield is not automatically a better income stream.
Is IBLHL Shariah-compliant on the PSX?
+
Yes. The Pakistan Stock Exchange lists IBLHL in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.
Which PSX indices is IBLHL part of?
+
IBLHL is a constituent of the KSE All Share and KMI All Share. It is not in the KSE-100, the headline PSX benchmark. Index membership is taken from the exchange's own published listing for each session.
Is IBLHL expensive? What are its valuation ratios?
+
IBLHL trades on a price-to-earnings ratio of 16.8, so the market is paying about Rs 16.8 for each rupee of annual earnings, earnings per share of Rs 2.43, a price-to-book ratio of 3.67 and a return on equity of 6.2%. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the AI forecast for IBLHL?
+
Our model currently reads IBLHL as strong sell over a short term horizon, at 60% confidence, with a target price of Rs 43.50. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its backtested hit rate on this specific stock is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for IBLHL are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.